Montu bids to ‘dispel myths’ as senior exec rejects claims of unethical practices by Steve Jones March 13, 2024March 13, 2024 Montu’s second-in-command has maintained the company is not afraid to make money from medicinal cannabis, but […]
Launch of consumer strategy ‘not taken lightly’, as ECS Botanics looks to capitalise on ‘unique IP’ by Steve Jones March 11, 2024March 11, 2024
Optimism turns to concern as Cann Group battles financial uncertainty by Steve Jones March 7, 2024March 7, 2024
Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth by Steve Jones March 7, 2024March 7, 2024
Lyphe Australia MD Tracey Loton to go it alone after exiting business by Steve Jones March 6, 2024March 6, 2024
Ecofibre directors ‘unjustly enriched’, former executive alleges as legal action is lodged in the US by Steve Jones March 5, 2024March 5, 2024
Health House parent becomes latest to report financial woes despite revenue growth by Steve Jones March 4, 2024March 6, 2024
Althea to cut further costs amid cash flow concerns and ongoing losses by Steve Jones March 1, 2024March 4, 2024
Cann Group shares suspended as auditor reports ‘insufficient evidence’ of future funding by Steve Jones March 1, 2024March 1, 2024